Children Attending Paediatricians Study: a national prospective audit of outpatient practice from the Australian

Harriet Hiscock1, Gehan Roberts, Daryl Efron

  • 1Royal Children's Hospital, Melbourne, VIC. harriet.hiscock@rch.org.au

Insights

Australian paediatricians manage complex cases with multiple diagnoses, often billing for single issues. This audit highlights the need for better workforce planning and training to address the complexity of paediatric care.

Area of Science:

  • Paediatric Medicine
  • Health Services Research
  • Clinical Audit

Background:

  • General paediatric outpatient practice in Australia involves diverse consultation types and management patterns.
  • Understanding these practices is crucial for improving healthcare delivery and training.

Purpose of the Study:

  • To audit Australian general paediatric outpatient practice.
  • To analyze consultation characteristics, management patterns, diagnoses, associated factors, and billing practices.

Main Methods:

  • Prospective data collection from Australian Paediatric Research Network (APRN) members.
  • Standardized forms used for 8345 consultations over a 2-week period in 2008.

Main Results:

  • A mean of 1.8 diagnoses per consultation, with many cases involving multiple or complex conditions.
  • Attention deficit hyperactivity disorder, baby checks, and learning difficulties were common diagnoses.
  • Paediatricians often billed for single diagnoses despite managing multiple issues.

Conclusions:

  • Australian paediatricians encounter a wide spectrum of diagnoses, frequently complex and multiple.
  • Findings can inform future research, workforce planning, and paediatrician training needs.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...